Related Experiment Videos

Increased cis-atracurium requirements during prolonged administration to a child

J D Tobias1

  • 1Department of Child Health, University of Missouri, Columbia 65212, USA.

Insights

Critically ill infants receiving prolonged cis-atracurium infusions for neuromuscular blockade may require significantly increased doses. Continuous monitoring with a peripheral nerve stimulator is essential for dose titration.

Area of Science:

  • Critical Care Medicine
  • Pediatric Anesthesiology
  • Pharmacology

Background:

  • Prolonged mechanical ventilation in infants necessitates neuromuscular blockade.
  • Cis-atracurium is a commonly used neuromuscular blocking agent.
  • Previous studies in adults showed stable cis-atracurium requirements over shorter durations.

Observation:

  • A seven-month-old infant required mechanical ventilation and neuromuscular blockade for six weeks due to multi-system organ failure.
  • Cis-atracurium infusion rates were adjusted based on train-of-four monitoring.
  • Initial infusion requirements of 2.8 mcg/kg/min increased to 22.3 mcg/kg/min by day 40.

Findings:

  • Significant increases in cis-atracurium infusion requirements were observed during prolonged administration in a critically ill infant.
  • The dose escalation was necessary to maintain adequate neuromuscular blockade over a six-week period.
  • This contrasts with findings in adult patients with shorter infusion durations.

Implications:

  • Clinicians should anticipate and monitor for escalating cis-atracurium requirements in infants undergoing prolonged mechanical ventilation.
  • Peripheral nerve stimulator monitoring is crucial for accurate dose titration and patient safety.
  • Further research is warranted to understand the mechanisms behind increased cis-atracurium tolerance in pediatric critical care settings.
Abstract

Related Concept Videos